Thursday 25 Aug 2016
Today’s issue of PD
Pharmacy Daily today has three pages of news, plus a full page from Amcal.
Guild eye care course The Guild Pharmacy Academy, Optometry Australia and Alcon Pharmaceuticals are working together on a new online course titled ‘Pharmacy Health Solutions: Eye Care’. The program aims to assist pharmacists in the appropriate management of self-limiting conditions of the eye with nonprescription medicines. Optometry Australia national professional services manager Luke Arundel said the project was an important collaboration, which would help strengthen relationships between the professions. See www.myCPD.org.au.
PHARMACYDAILY.COM.AU
EBOS reports 2016 record EBOS Group this morning unveiled its financial results for the year to 30 Jun, with EBIT earnings surging 16.3% to exceed NZ$200 million for the first time. The net profit after tax was NZ$127 million, achieved on total revenues of NZ$7.1 billion, with ceo Patrick Davies saying “the result reflects our ability to capture the growth opportunities that continue to emerge within our prime business segments”. In the key Australian pharmacy market EBOS saw “solid wholesale revenue growth” which was boosted by increased levels of activity in the OTC channel. Revenue jumped 19.6%, accelerating in Mar 2016 when the government PBS listed the new specialty Hepatitis C medicines. As well as wholesaling the Hep C drugs, EBOS was contracted to
Perjeta AusPAR Perjeta (pertzumab) from Roche Products has had its extension of indication approved and detailed in the latest AusPAR addition. The product is now indicated in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of patients with inflammatory or locally advanced HER2 positive breast cancer as part of a complete treatment regimen. Visit www.tga.gov.au for details.
provide the third party logistics for the medicines. “EBOS today continues to expand the breadth and depth of services it offers multinational suppliers, well beyond that of the traditional wholesale model,” Davies said. “We are actively working on further opportunities to expand our unique trans-Tasman business solutions model by partnering with manufacturers to provide a wide range of valued services,” he said. During the year EBOS invested $17.6 million in capital works, including a new $3.9 million Sydney warehouse specifically commissioned to undertake the NSW Government’s medical consumables contract. The company is also developing a new $58 million distribution facility in Brisbane, which is expected to be operational by Jun 2018, as well as another new warehouse in Sydney to cater for growth in the EBOS contract logistics operations, at a cost of about $15.5 million. Davies said the company was confident of further profit growth into the current financial year.
ASMI earlybird Prospective attendees at the upcoming Australian SelfMedication Industry conference are reminded earlybird registration expires on 31 Aug - CLICK HERE.
PSA CPD workshops The Pharmaceutical Society of Australia says there’s been a huge response to its current series of Continuing Professional Development workshops, with more than 1,500 pharmacists already registered to attend the events in Aug and Sep. The sessions are to showcase the new free PSA CPD Planning Tool, which was officially launched at PSA16 Sydney (PD 04 Aug). “This user-friendly learning tool has been embraced by the entire pharmacy profession and it’s fantastic to see so many pharmacists - including PSA nonmembers - registering for PSA workshops to learn more about CPD learning,” said PSA National Vice President, Michelle Lynch. For details of upcoming workshops in each state and territory see psa.org.au.
Zero Out of stocks
Want to know how Amneal can eliminate costly out of stocks in your pharmacy?
Click here As of 25 August 2016
Pharmacy Daily Thursday 25th August 2016
t 1300 799 220
w www.pharmacydaily.com.au
page 1